It was demonstrated that DTPA (diethylenetriaminepentaacetic acid) enhanced the vascular permeability by the intradermal injection test in rats. This change was inhibited by the pretreatment of Epinephrine (vasoconstrictor).
I INTRODUCTION
DTPA (diethylenetriaminepentaacetic acid) has been known as the chelating agent that can decorporate effectively plutonium and other actinides.1-4) However, it is necessary to determine whether DTPA has side effects and to establish the method of prevention against side effects, before it is applied clinically to the human. This problem must be solved as soon as possible, because the actual accidents had already occurred in which DTPA had been administered to the human. 5, 6) body weight) of Zn-DTPA or 10 H.D. of Ca-DTPA was administered orally to rats, the congestion and hemorrhage in the small intestine were observed.7) The similar changes and the hemosiderin deposition outside the vessels in the lamina propria of the small intestine were also seen in beagle dogs when 1 H.D. of Zn-DTPA was administered orally.8) Various side effects of DTPA after variable administration routes with regard to the vascular system have been reported by many investigators.9-11) From these findings, it is likely that DTPA could have some actions to affect the vascular system.
In the present study, it was elucidated, in the first place, that DTPA enhanced the vascular permeability when the test methods was applied which had been used in the passive cutaneous anaphylaxia test of drugs.12) In the next place, it was observed that the enhancement of vascular permeability was induced by the intravenous injection of DTPA and the direct administration of DTPA into the gastro-intestinal tract of rats, to be considered as practical administration routes to humans. The relationships between the enhanced vascular permeability and the side effects with congestion and hemorrhage were discussed. 
Tests for vascular permeability
The following four tests were carried out after rats were anethtized with ketamine hydrochroride (Sankyo Co., Ltd.).
(1) In order to clarify that DTPA enhances the vascular permeability, this test was carried out, according to the test method of the passive cutaneous anaphylaxia test of drugs.12)
Either Ca-DTPA and Zn-DTPA solution of various dilutions or isotonic saline solution as control was injected intradermally in 0.05ml into the shaved dosal skin of rats. In order to observe clearly the vascular permeability, rats were injected intravenously in 0.5ml of 1% solution of Evans Blue dye (E. Merk A G.), 10 and 30min, 1, 3 and 5hr after the intradermal injection of DTPA solutions. Rats were sacrificed 20min after the administration of dye. The dorsal skin was reflexed, and the degree of vascular permeability change was determined by measuring the mean diameter of blueing site induced by the extravasation of dye and its intensity was checked.
(2) In order to assess that the increase of vascular permeability is caused by the direct action to vessel of DTPA. Epinephrine (0.08mg/kg body weight), as a vasoconstrictor, was injected intramuscularly to rats. Five or 20min following the pretreatment of Epinephrine, serial dilutions of DTPA and isotonic saline solution were injected intradermally to rats. After 10min, rats were injected intravenously in 0.5ml of 1% Evans Blue dye. Thereafter, the degree of vascular permeability change was observed in the same manner as the described above.
(3) This test was done to observe whether the vascular permeability increased by the intravenous (4) This test was done to observe whether the vascular permeability increases by the oral administration of DTPA or not.
III RESULTS
(1) The vascular permeability changes, which showed blueing induced by the extravasation of Evans Blue dye in the rat skin, were observed by the intradermal injection of DTPA (Fig. 1) . The (2) The enhanced vascular permeability induced by both Ca-DTPA and Zn-DTPA were inhibited by the treatment with Epinephrine prior to DTPA intradermal injections (Table 2 and Fig. 3 ). The enhancement of vascular permeability of Ca-DTPA was suppressed more strongly than that of Zn-DTPA.
(3) When Zn-DTPA was injected intravenously to rats, the increase of vascular permeability was seen in the duodenum, jejunum and ileum (30-50 Fig. 2 Mean diameters of blueing circles induced by Ca-DTPA and Zn-DTPA 10min after intradermal injection. Table 1 The mean diameters of blueing circles and its intensity showing the degrees of vascular permeability changes induced by DTPA when injected intradermally to rats.
Intensity of the extravasation of blue dye indicated by + (pale) or ++ (strong). Number of parentheses presented animals showing blueing changes. Table 2 The suppression of vascular permeability by the treatment of Epinephrine prior to DTPA intradermal injection.
Number of parentheses presented animals showing blueing changes. Fig. 3 The suppression of vascular permeability by the treatment of Epinephrine (0.08mg/kg body weight) 5min prior to DTPA -intradermal injection. Fig. 4 The intensity of extravasation of dye in the gastro-intestinal tract induced by Zn-DTPA when injected intravenously to rats. Three animals were used in each group. Intensity of extravasation of dye indicated by -(negative), + (mild), ++ (moderate), respectively. the direct action to the vasculature. The blueing circles reached the maximum within 10 min after the intradermal injection of DTPA, and were observed 5hr later (Table 1 ). This shows that the effects of DTPA on vascular permeability appear immediately after DTPA administration and continue for a long time.
The enhancement of vascular permeability by Ca-DTPA was stronger than that of Zn-DTPA (Table 2 ). This supported that Ca-DTPA was more toxic than Zn-DTPA, as many investigators already reported.4,10,13,14) The vascular permeability of Ca-DTPA was inhibited more strongly by Epinephrine than that of Zn-DTPA. This might reflect the differences in kinetics of Ca2+ ions the vasculature. 15) Most noticeable finding was the blueing changes in the small intestine when DTPA was injected intravenously to rats. Because the intravenous injection of DTPA is considered to be a safe administration route to humans. TAYLOR et al. reported that the hemorrhages in the mucosa of duodenum were observed in the beagle dogs to which DTPA was injected intravenously and subcutaneously.11) Therefore, it was estimated that the hemorrhage in the gastro-intestinal tract could be induced by the vascular permeability action of DTPA.
The intensive extravasation of dye was observed in the small intestine by the direct administration of Zn-DTPA. BALLOU and PALOTAY reported the absorbed sites of DTPA in the rat administered orally were the jejunum and ileum.16) We observed the vasodilation, exudation of the blood and deposition of hemosiderin outside the vessels in the lamina propria of the small intestine of rats and beagle dogs administered orally.7,8) The intestinal disturbances and its related clinical signs, i.g., loss of appetite, diarrhea, vomiting, melena were observed regardless of administration routes of DTPA, although those causes had been obscure. 10, 11, 17) It is likely that the gastro-intestinal tract is more sensitive to DTPA. SPENCER and ROSOFF observed thedecr ease of blood pressure with bradycardia continued 2-4hr after DTPA intravenous injection in the patient.9) This finding is corresponding to our results in which the increase of vascular permeability changes continued for 5 hr after the intradermal injection of DTPA. TAYLOR et al. observed the hemorrhages, ranged from small petechiae to frank effusions in the lung, adrenal and thymus, and hypermia in the medullary of kidney and congestion in the liver of beagle dogs injected intravenously or subcutaneously.11) Although no evidences were proposed, the medical stuffs took care of cardiac status of the patient in Hanford americium accident when tried the protracted therapy of DTPA administration (1-2g/day).5) Hence, the detailed pharmacological evidence on the enhancement of vascular permeability of DTPA and the relationship between clinical signs and schedule of DTPA administration should be necessary to be investigated as soon as possible.
V CONCLUSIONS
It was found that DTPA enhanced the vascular permeability by the extravasation test of Evans Blue dye. It is estimated that this change will be related to various side effects with hemorrhage and congestion induced by DTPA. Therefore, it was suggested that DTPA should be cautiously treated to humans.
